Article
Development of a BRET2 screening assay using beta-arrestin 2 mutants.
Journal of biomolecular screening - 1 Jun 2004
Vrecl Milka, Jorgensen Rasmus, Pogacnik Azra, Heding Anders
Abstract excerpt
This study has focused on enhancing the signal generated from the interaction between a G-protein-coupled receptor (GPCR) and beta-arrestin 2 (beta-arr2), measured by the bioluminescence resonance energy transfer (BRET(2)) technology. Both class A (beta(2)-adrenergic receptor [beta(2)-AR]) and class B (neurokinin-type 1 receptor [NK1-R]) GPCRs, classified based on their internalization characteristics, have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
